Author

R. Sklavenitis-Pistofidis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:clustering· 1 Approach:deep learning· 1

Frequent Co-Authors

G. Getz· 3 shared I. M. Ghobrial· 3 shared A. Dutta· 2 shared D. Heilpern-Mallory· 2 shared J.-B. Alberge· 2 shared M. Rahmat· 2 shared A. J. Dunford· 1 shared B. A. Walker· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

G. Getz

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 1, 2023

Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors

R. Sklavenitis-Pistofidis, E. D. Lightbody, M. Reidy…·S. Manier

DOI 10.1101/2023.08.01.551480

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 19, 2023

Novel mechanism of MYC deregulation in Multiple Myeloma

M. Rahmat, K. Clement, J.-B. Alberge…·I. M. Ghobrial

The paper identifies a new epigenetic mechanism of MYC deregulation in multiple myeloma through enhancer accessibility and transcription factor binding, independent of translocations or amplifications.

DOI 10.1101/2023.05.19.541506

humanDNA methylation

𝕏 PostBluesky

Cancer BiologybioRxivDec 10, 2021

Genetic Subtypes of Smoldering Multiple Myeloma are associated with Distinct Pathogenic Phenotypes and Clinical Outcomes

M. Bustoros, S. Anand, R. Sklavenitis-Pistofidis…·I. M. Ghobrial

This study identifies six genetic subtypes of smoldering multiple myeloma associated with distinct clinical outcomes and progression risks.

DOI 10.1038/s41467-022-30694-w

humanbulk RNA-seq

𝕏 PostBluesky